A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease.
Although statins have been shown to reduce the risk of developing Alzheimer's disease in some studies see Alzheimer''s risk factors , simvastatin was ineffective in patients already afflicted with mild to moderate Alzheimer's disease, despite lowering cholesterol levels: Tweet
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment